BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 35999621)

  • 1. Physio-pathological effects of N6-methyladenosine and its therapeutic implications in leukemia.
    Liu WW; Wang H; Zhu XY
    Biomark Res; 2022 Aug; 10(1):64. PubMed ID: 35999621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases.
    Zhang B; Jiang H; Dong Z; Sun A; Ge J
    Genes Dis; 2021 Nov; 8(6):746-758. PubMed ID: 34522705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology.
    Fang X; Li M; Yu T; Liu G; Wang J
    Genes Dis; 2020 Dec; 7(4):585-597. PubMed ID: 33335958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
    Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
    BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer.
    Tian S; Lai J; Yu T; Li Q; Chen Q
    Front Oncol; 2020; 10():623634. PubMed ID: 33552994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functions of N6-methyladenosine modification in lncRNAs.
    He RZ; Jiang J; Luo DX
    Genes Dis; 2020 Dec; 7(4):598-605. PubMed ID: 33335959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine (m6A) methylation in kidney diseases: Mechanisms and therapeutic potential.
    Sun Y; Jin D; Zhang Z; Ji H; An X; Zhang Y; Yang C; Sun W; Zhang Y; Duan Y; Kang X; Jiang L; Zhao X; Lian F
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194967. PubMed ID: 37553065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of RNA N
    Teng C; Kong F; Mo J; Lin W; Jin C; Wang K; Wang Y
    Heliyon; 2022 Nov; 8(11):e11430. PubMed ID: 36387447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of N6-methyladenosine modification in the development of Parkinson's disease.
    Zhou J; Han Y; Hou R
    Front Cell Dev Biol; 2023; 11():1321995. PubMed ID: 38155838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of N6-methyladenosine RNA modification in gastric cancer.
    Ding SQ; Zhang XP; Pei JP; Bai X; Ma JJ; Zhang CD; Dai DQ
    Cell Death Discov; 2023 Jul; 9(1):241. PubMed ID: 37443100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N6-methyladenosine RNA modifications: a potential therapeutic target for AML.
    Hu R; Liao P; Xu B; Qiu Y; Zhang H; Li Y
    Ann Hematol; 2023 Aug; ():. PubMed ID: 37548690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours.
    Xia Z; Kong F; Wang K; Zhang X
    Front Pharmacol; 2022; 13():908079. PubMed ID: 35754499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of N6-Methyladenosine Modification in Tumors.
    Zhang N; Zuo Y; Peng Y; Zuo L
    J Oncol; 2021; 2021():6461552. PubMed ID: 34858499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
    Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
    Front Oncol; 2022; 12():927640. PubMed ID: 35936737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
    Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
    Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
    Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
    Front Oncol; 2021; 11():635329. PubMed ID: 33928028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer.
    Liu Q
    Front Genet; 2021; 12():825109. PubMed ID: 35087575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress of N6-methyladenosine in colorectal cancer: A review.
    Lin Y; Shi H; Wu L; Ge L; Ma Z
    Medicine (Baltimore); 2023 Nov; 102(47):e36394. PubMed ID: 38013272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functions of RNA N
    Zheng X; Gong Y
    Biomark Res; 2021 May; 9(1):36. PubMed ID: 34001273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research progress concerning m
    Zhou Y; Yang J; Tian Z; Zeng J; Shen W
    Oncol Lett; 2021 Nov; 22(5):775. PubMed ID: 34589154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.